HYPOSIDERAEMIA

HYPOSIDERAEMIA was reported 74 times

HYPOSIDERAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 1 0.0001
1 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
2 Nucleoside Metabolic Inhibitor [EPC] 27 0.0001
3 Platinum-based Drug [EPC] 26 0.0001
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 11 0.0001
5 Microtubule Inhibitor [EPC] 9 0.0001
6 Epidermal Growth Factor Receptor Antagonist [EPC] 2 0.0000
7 Alkylating Drug [EPC] 6 0.0000
8 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
9 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
10 Methylxanthine [EPC] 1 0.0000
11 Cardiac Glycoside [EPC] 1 0.0000
12 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
13 Proton Pump Inhibitor [EPC] 6 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
15 Parathyroid Hormone Analog [EPC] 1 0.0000
16 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
17 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
18 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
19 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
20 Kinase Inhibitor [EPC] 3 0.0000
21 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
22 Thiazide Diuretic [EPC] 1 0.0000
23 Vitamin C [EPC] 2 0.0000
24 Loop Diuretic [EPC] 2 0.0000
25 Vitamin D [EPC] 1 0.0000
26 Vitamin B12 [EPC] 1 0.0000
27 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
28 Atypical Antipsychotic [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Corticosteroid [EPC] 2 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000